Treatment with dexamethasone, commonly used as ITP therapy restored the expression of miR-125a-5p in ITP CD4+ T cells, likely by suppressing MEG-3; it also promoted Treg differentiation. Here, MEG3 is linked to autoimmune thrombocytopenic purpura.